Genentech BD director reviews recent technology deals

Mark Rowen, associate director of business development at Genentech, talks to Scrip at BIO-Europe Spring 2018 about the company's recent technology deals with DiCE Molecules and FinnGen. He also outlines the challenges around introducing multiple new partnerships into the business and the goals for Genentech for the rest of the year when it comes to seeking innovative new tools for drug development.